Clinical Trials
We are focused on the development of a broad pipeline of innovative, transformative therapies for oncology patients.
Investors & Media
Stemline is a commercial-stage biopharmaceutical company committed to applying our scientific leadership and commercial expertise to transform the lives of patients with cancer.
Visit BPDCNinfo.com
A resource for patienys with blastic plasmacytoid dendritic cell neoplasm. Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) is an aggressive and deadly blood cancer that often presents with skin lesions.
The Menarini Group
The Menarini Group is present in 140 countries worldwide, a guarantee of internationally recognised quality. The achieved results are proof of an efficient strategy based on Research, Innovation and Internationalisation, along with the ability to recognize and meet the needs of physicians and patients alike.